SVANOVIR® BLV gp51-Ab is based on the gp51 envelope protein, enabling the detection of antibodies to BLV during early phase of infection. It fulfils the EU standard E05 (EEC directive 88/406/EEC) for serum/plasma and milk, and has been used successfully in BLV eradication and control programmes worldwide.

SVANOVIR® BLV gp51-Ab

The early indicator for bovine leukaemia virus infection (BLV) in cattle

Product Information

Species Bovine
Samples Serum, plasma, individual and pools of ≤ 10
Milk, individual and pools of ≤50
Type Indirect ELISA based on the envelope glycoprotein gp-51
Article number Samples* Plates Format
104884 88 2 Strips
104885 440 10 Plates
104886 920 10 Strips

*Samples: Max. number of samples for analysis, wells for kit controls excluded